XENIA PHARMA ApS: Financial statements 2022
CVR: 35529454
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
XENIA PHARMA ApS (CVR 35529454) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -53,707 and a net result of DKK -51,320 compared with DKK -27,504 the year before. Equity in the 2022 report amounted to DKK -18,771.
- Gross Profit
- DKK -53,707
- Profit/Loss
- DKK -51,320
- Equity
- DKK -18,771
- Total Assets
- DKK 43,172
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -54K | -51K | -19K | - |
| 2021 | - | -27K | -28K | -19K | - |
| 2020 | - | -2K | -2K | -1K | - |
| 2019 | - | -3K | -3K | 789 | - |
| 2018 | - | -25K | -25K | 4K | - |
Official annual report
Keep an eye on XENIA PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
XENIA PHARMA ApS has published its annual report for 2021. Gross profit came to DKK -27,490, and the net result was DKK -27,504.
About XENIA PHARMA ApS
XENIA PHARMA ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2013. The company is registered under the industry Dyrlægeaktiviteter. The management consists of Dorte Xenia Gram. The company is owned by Dorte Xenia Gram. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -28,827 and a net result of DKK -28,855 compared with DKK -18,952 the year before. Equity in the 2025 report amounted to DKK -46,501.